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Abstract 
Review on GPX3, with data on DNA, on the protein 
encoded, and where the gene is implicated. 
Keywords 
GPX3; Glutathione peroxidase 3 
Identity 
Other names: GPX-P, GSHPX-3, GSHPX-P 
HGNC (Hugo): GPX3 
Location: 5q33.1 
DNA/RNA 
Transcription 
Human GPx3 gene is transcribed to the GPx3 
transcript of 1779 bp (NM_002084), consisting of 
exon 1 (1-304 bp), exon 2 (305-458), exon 3 (459-
576), exon 4 (577-676), and exon 5 (677-1761).  
The coding DNA sequence (CDS) 218..898 bp, 
encodes for a protein of 226 aa, comprising a leading 
signal peptide sequence at 218..277 bp followed by 
the main coding sequence for GPx3. An OPAL 
codon (TGA) at 434-436 bp is translated to a 
Selenocycteine (Chambers et al. 1986; Fu et al. 
2002; Fu et al. 2002). 
Pseudogene 
Unknown. 
Description 
Plasma glutathione peroxidase 3 is a member of 
glutathione peroxidase family, and is the only 
secretary glutathione peroxidase, accounting for the 
all glutatione peroxidase in extracellular 
compartment. Structurally, intracellular GPx3 has a 
leading signal peptide. GPx3, similar to other 
selenoproteins, contains a UGA OPAL codon at 
codon 73, which is coded for a selenocystein residue 
in the presence of selenium.  
The human GPx3 gene is located at the forward strand of chromosome 5 in the region between 151,020,438 to 151,028,993 bps 
(GRCh38), comprising 5 exons and adjacent to TNIP1 gene. There are 10 to 11 variant transcripts of GPx3, but only 7 are 
processed as proteins, according Ensemble Genome Browser database (ENSG00000211445), of which only one with known 
function (NCBI database). 
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Protein 
Expression 
GPx3 is a plasma glutathione peroxidase, being 
secreted to extracellular compartment after 
synthesized in cells. GPx3 mRNA is expressed in 
different tissues, lung, heart, breast, prostate, 
placenta,and kidney. But majority (almost 70%) of 
plasma GPx3 is thought kidney originated(Avissar et 
al. 1994; Tham et al. 1998). GPx3 is transported 
through circulation and binds to the basement 
membrane of epithelia of GI (Burk et al. 2011). 
GPx3 mRNA is detected in a variety of tissues, while 
most of them are not joining in the plasma GPx3(Chu 
et al. 1992; Maeda et al. 1997; Tham, Whitin et al. 
1998), implicating the unknown function of GPx3 in 
other tissues or organs. 
Function 
Glutathione peroxydase 3, as other tetrameric GPx 
enzymes using reduced glutatione as electron donor, 
catalyses the oxydation of reduced glutathione and 
the simultaneous reduction of a variety of hydrogen 
peroxide and organoperoxides. As a result, the GPx3 
functions in the system to relieve oxidative stress as 
an antioxidant enzyme. The catalytic residues in 
GPx3 have been mapped to the location of U73, 
Q107 and W181(Ren et al. 1997). U73 codes for 
selenocycteine, a residue that is involved in the 
reduction of hydrogen peroxide in a catalytic cycle 
of its atom, from reduced selenolate anion (R-se) to 
oxidized selenic acid (R-Se-OH). Latter regenerates 
selenolate anion by GSH. In physiological PH, 
selenole forms anion, a good reducing source in the 
system(Ren, Huang et al. 1997). However, electron 
donor GSH is limited in the extracellular space, 
implicating a rate limiting factor in the antioxidative 
function of GPx3. Conserved domain analysis 
classifies glutathione peroxidase as thioredoxin-like-
superfamily protein (Conserved domains 
database[gi|6006001|ref|NP_002075|]). 
In recent studies, GPx3 protein expression was found 
in a variety of normal tissues or cells, while down-
regulated in a number of cancers.  
Through Yeast Two-Hybrid analyses, GPx3 was 
found interacting with several proteins in cells. One 
of such proteins is a TP53 transactivated protein, 
PIG3, which positively regulates apoptosis and 
mediates UV-induced cell death. The interaction 
between GPx3 and PIG3 leads to apoptotic cell 
death. GPx3 with mutated OPAL codon retains its 
capabilities in promoting cell death, suggesting that 
GPx3 contains pro-apoptotic activity independent of 
its peroxidase function(Wang et al. 2012). 
 
Homology 
Glutathion peroxidase activity of GPx3 is conserved 
in other seven GPx selenocysteine containing 
proteins. Though encoded from different genes, all 
contain a common UGA OPAL codon, encoding a 
selenocysteine residue in coding region, an active 
site of enzyme activity(Tosatto et al. 2008). GPx3 
sequence, if excluding signal peptide, has the highest 
homology (84%) and identities (72%) with GPx5 
encompassing 200 out of 226 aa in the coding region; 
while 60% homology with GPx1, GPx2 ; but low, 
46-47% with GPx4,6,7,and 8. 
GPx3 is expressed in other species. Human GPx3 
shares sequece homology (94%) and identities 
(89%) with mouse GPx3 over 226 aa including 
signal peptide sequence; 95-96% homology and 91-
92% identities with rat(NP_071970.2)and dog 
(NP_001157926.1) of full coding region, but is of 
only limited homology to GPx3 in Xenopus Laevis 
(NP_001085319.2)and Zebra fish 
(NP_001131027.1). 
Mutations 
Note 
Not known. 
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Expression and methylation of GPx3 gene in multiple cancer cell lines(Yu et al. 2004; Yu, Yu et al. 2007; Chen, Rao et al. 2011) 
 
 
Implicated in 
Prostate cancer 
Oncogenesis 
Silencing of GPx3 gene with hypermethylation of 
GPx3 promoter was first found in a microarray study 
of three prostate cancer cell lines, in which treated 
with 5-aza-2' deoxycytidine, GPx3 expression was 
induced in these cells originally silenced in GPx3 
(Lodygin et al. 2005). GPx3 down-regulation was 
subsequently confirmed in several gene expression-
array analyses of a large number of human prostate 
cancer specimens with high rate of occurrence 
(LaTulippe et al. 2002; Luo et al. 2002; Yu, 
Landsittel et al. 2004; Yu, Yu et al. 2007). Complete 
inactivation of GPx3 was closely correlated with the 
poor clinical outcome of prostate cancer. 
Hemizygous and homozygous deletion of GPx3 
gene occurs in a subset of prostate cancer 
samples(39%). CpG island hypermethylation in 
GPx3 promoter occurs in over 90% of prostate 
cancer samples (Lodygin, Epanchintsev et al. 2005; 
Yu, Yu et al. 2007). The frequent CpG 
hypermethylation in GPx3 in cancer suggests that 
hypermethylation plays a significant role in GPx3 
down-regulation in cells. Down-regulation of GPx3 
increases these cell's vulnerability to oxidative 
damages. Conditions predisposed to prostate cancer, 
such as high animal fat diet in TRAM mice and loss 
of tumor suppressor Nkx3.1, has been found 
accompanied with decrease in GPx3 expression in 
animal (Chang et al. 2014), (Ouyang et al. 2005). 
Cervical cancer 
Oncogenesis 
GPx3 is down-regulated in cervical cancer tissues 
when compared with normal cervical tissues, and the 
down-regulation is closely correlated to lymph node 
metastasis and prognosis in cervical cancer patients. 
Promoter methylation is the major cause of GPX3 
down-regulation(Zhang et al. 2014). 
Esophageal squamous cell 
carcinoma(ESCC) and Barrett's 
adenocarcinomas (BA) 
Oncogenesis 
Down-regulation of GPx3 expression in ESCC was 
revealed in a DNA micro-array study and GPx3 gene 
methylation was indicated by demethylation 
treatment of ESCC tissues with 5-aza-2'-
deoxycytidine, where GPx3 expression was restored 
in 71.4% of tumor samples and 10.7% of adjacent 
normal tissues(He et al. 2011). The GPx3 gene 
methylation was significantly correlated with the 
downregulation of GPx3 mRNAs in tumors.  
In Barrett's adenocarcinomas (BA), quantitative RT-
PCR revealed 91% of tumor samples with reduced 
levels of GPx3 mRNA. Similarly, GPx3 promoter 
hypermethylation was detected in 88% of BA 
samples with the mostly bi-alleles 
hypermethylation(Lee et al. 2005; Peng et al. 2009). 
Gastric cancer 
Oncogenesis 
Down-regulation of GPx3 expression in gastric 
cancer was identified in gastric cancer tissues, which 
displayed a high occurrence rate of 8/9 cancer cell 
lines, and 83% (90/108) of gastric cancer samples.  
Hypermethylation of GPx3 promoter in 6 out of 9 
cancer cell lines and 60% of gastric cancer samples 
significantly contributed to the silencing of GPx3 
gene(Zhang, Yang et al. 2010; Peng et al. 2012), 
although loss of copy number of GPx3 gene was also 
detected in the cancer samples. Silencing of GPx3 
was correlated to the lymph node metastasis of 
gastric cancer and was also detected in the adjacent 
normal gastric tissue samples, suggestive of cancer 
field effects in gastric tract. In addition, a study 
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showed that two intronic SNPs in GPx3 significantly 
altered gene expression, a possible link to the 
increasing risks of gastric cancer (Wang et al. 2010). 
Wound healing analyses showed that retoring GPx3 
expression in cells decreased cell motility, a possible 
feature involved in cancer metastasis. 
Breast cancer 
Oncogenesis 
Down-regulation of GPX3 expression in breast 
cancer was identified through 
immunohistochemistry (IHC) analyses of breast 
cancer samples by comparing with the normal 
tissues. The inflammatory breast cancer (IBC), with 
higher frequency of GPx3 promoter methylation, 
had GPx3 expression significantly lower than those 
in non-inflammatory breast cancer (non-
IBC)(Mohamed et al. 2014). 
Ovarian carcinoma 
Oncogenesis 
Similar to breast cancer, abberation of GPx3 
expression in ovarian cancer distinguishes cancer 
stage and cell type of ovarian cancer ; Decreased 
levels of serous glutathione peroxidase 3 were 
associated with late stages of papillary serous 
ovarian cancer or disease progression(Lau et al. 
2014), while clear cell subtype showed elevated 
GPx3 expression(Hough et al. 2001). 
Colorectal Carcinoma 
Oncogenesis 
Tumor suppression of GPx3 in the inflammatory 
colonic tumorigenesis (colitis associated carcinoma) 
model was suggested in the GPx3-knockout mice as 
the manifestation of the increased number of tumor 
with higher degree of dysplasia in colon. 
Knockdown of GPx3 in the colon cancer cell line 
resulted in increase of inflammation, proliferation, 
DNA damage and apoptosis following the exposure 
to oxidative stress (Barrett et al. 2013).  Genotype 
analyses of three SNPs in GPx3 indicates that the 
genetic variations in GPx3 contribute to the risk of 
rectal cancer (Haug et al. 2012) 
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